Page 12 - 2022-06-中国全科医学

http://www.chinagp.net E-mail:zgqkyx@chinagp.net.cn ·649·

Effects of a high vs moderate volume of aerobic exercise on adiposity J Am Coll Cardiol，2012，60（15）：1374-1380. DOI：
outcomes in postmenopausal women［J］. JAMA Oncol，2015，1 10.1016/j.jacc.2012.05.037.
（6）：766. DOI：10.1001/jamaoncol.2015.2239. ［28］SJÖSTRÖM L，PELTONEN M，JACOBSON P，et al. Bariatric
［17］RABKIN S W，CAMPBELL H. Comparison of reducing epicardial surgery and long-term cardiovascular events［J］. JAMA，2012，
fat by exercise，diet or bariatric surgery weight loss strategies：a 307（1）：56-65. DOI：10.1001/jama.2011.1914.
systematic review and meta-analysis［J］. Obes Rev，2015，16（5）： ［29］The Look AHEAD Research Group. Association of the magnitude
406-415. DOI：10.1111/obr.12270. of weight loss and changes in physical fitness with long-term
［18］MURPHY J C，MCDANIEL J L，MORA K，et al. Preferential cardiovascular disease outcomes in overweight or obese people
reductions in intermuscular and visceral adipose tissue with with type 2 diabetes：a post-hoc analysis of the Look AHEAD
exercise-induced weight loss compared with calorie restriction［J］. randomised clinical trial［J］. Lancet Diabetes Endocrinol，2016，
J Appl Physiol，2012，112（1）：79-85. DOI：10.1152/japplph 4（11）：913-921. DOI：10.1016/S2213-8587（16）30162-0.
ysiol.00355.2011. ［30］FISHER D P，JOHNSON E，HANEUSE S，et al. Association
［19］GALLAGHER D，HESHKA S，KELLEY D E，et al. Changes in between bariatric surgery and macrovascular disease outcomes in
adipose tissue depots and metabolic markers following a 1-year diet patients with type 2 diabetes and severe obesity［J］. JAMA，
and exercise intervention in overweight and obese patients with type 2018，320（15）：1570. DOI：10.1001/jama.2018.14619.
2 diabetes［J］. Dia Care，2014，37（12）：3325-3332. DOI： ［31］PAYVAR S，KIM S，RAO S V，et al. In-hospital outcomes of
10.2337/dc14-1585. percutaneous coronary interventions in extremely obese and normal-
［20］BOGERS R P. Association of overweight with increased risk of weight patients：findings from the NCDR （National Cardiovascular
coronary heart disease partly independent of blood pressure and Data Registry）［J］. J Am Coll Cardiol，2013，62（8）：692-
cholesterol levels：a meta-analysis of 21 cohort studies including 696. DOI：10.1016/j.jacc.2013.05.058.
more than 300 000 persons［J］. Arch Intern Med，2007，167（16）： ［32］BUSCHUR M，SMITH D，MOSCUCCI M，et al. The burgeoning
1720. DOI：10.1001/archinte.167.16.1720. epidemic of obesity in patients undergoing percutaneous coronary
［21］SCHINDLER T H，CARDENAS J，PRIOR J O，et al. intervention （PCI）：insight from the blue cross blue shield of
Relationship between increasing body weight，insulin resistance， Michigan cardiovascular consortium （bmc2）［J］. J Am Coll
inflammation，adipocytokine leptin，and coronary circulatory Cardiol，2012，59（13）：E54. DOI：10.1016/S0735-1097（12）
function［J］. J Am Coll Cardiol，2006，47（6）：1188-1195. 60055-2.
DOI：10.1016/j.jacc.2005.10.062. ［33］HOLROYD E W，SIRKER A，KWOK C S，et al. The relationship
［22］QUERCIOLI A，MONTECUCCO F，PATAKY Z，et al. of body mass index to percutaneous coronary intervention outcomes：
Improvement in coronary circulatory function in morbidly obese does the obesity paradox exist in contemporary percutaneous coronary
individuals after gastric by pass-induced weight loss：relation to intervention cohorts? Insights from the British cardiovascular
alterations in endocannabinoids and adipocytokines［J］. Eur Heart J， intervention society registry［J］. JACC：Cardiovasc Interv，
2013，34（27）：2063-2073. DOI：10.1093/eurheartj/eht085. 2017，10（13）：1283-1292. DOI：10.1016/j.jcin.2017.03.013.
［23］The Global Burden of Metabolic Risk Factors for Chronic Diseases ［34］TERADA T，FORHAN M，NORRIS C M，et al. Differences
Collaboration. Metabolic mediators of the effects of body-mass in short- and long-term mortality associated with BMI following
index，overweight，and obesity on coronary heart disease and coronary revascularization［J］. J Am Heart Assoc，2017，6（4）：
stroke：a pooled analysis of 97 prospective cohorts with 1.8 million e005335. DOI：10.1161/jaha.116.005335.
participants［J］. Lancet，2014，383（9921）：970-983. ［35］PARK D W，KIM Y H，YUN S C，et al. Association of body
DOI：10.1016/S0140-6736（13）61836-X. mass index with major cardiovascular events and with mortality after
［24］HIBBERT B，SIMARD T，WILSON K R，et al. Transradial percutaneous coronary intervention［J］. Circ Cardiovasc Interv，
versus transfemoral artery approach for coronary angiography and 2013，6（2）：146-153. DOI：10.1161/CIRCINTERVENTIO
percutaneous coronary intervention in the extremely obese［J］. NS.112.000062.
JACC：Cardiovasc Interv，2012，5（8）：819-826. DOI： ［36］MA W Q，SUN X J，WANG Y，et al. Does body mass index
10.1016/j.jcin.2012.04.009. truly affect mortality and cardiovascular outcomes in patients after
［25］ELAGIZI A，KACHUR S，LAVIE C J，et al. An overview coronary revascularization with percutaneous coronary intervention or
and update on obesity and the obesity paradox in cardiovascular coronary artery bypass graft? A systematic review and network meta-
diseases［J］. Prog Cardiovasc Dis，2018，61（2）：142-150. analysis［J］. Obes Rev，2018，19（9）：1236-1247. DOI：
DOI：10.1016/j.pcad.2018.07.003. 10.1111/obr.12713.
［26］CARBONE S，CANADA J M，BILLINGSLEY H E，et al. Obesity ［37］BHATT D L，GROSSER T，DONG J F，et al. Enteric coating
paradox in cardiovascular disease：where do we stand?［J］. Vasc and aspirin nonresponsiveness in patients with type 2 diabetes
Health Risk Manag，2019，15：89-100. DOI：10.2147/VHRM. mellitus［J］. J Am Coll Cardiol，2017，69（6）：603-612.
S168946. DOI：10.1016/j.jacc.2016.11.050.
［27］LAVIE C J，DE SCHUTTER A，PATEL D A，et al. Body ［38］BORDEAUX B C，QAYYUM R，YANEK L R，et al. Effect of
composition and survival in stable coronary heart disease：impact obesity on platelet reactivity and response to low-dose aspirin［J］.
of lean mass index and body fat in the “obesity paradox”［J］. Prev Cardiol，2010，13（2）：56-62. DOI：10.1111/j.1751-